
A 115-year farm discovered that preserving the legacy meant letting a new crop compete with it. Ayrloom reached Beak & Skiff's revenue scale in three years, then forced the family to reallocate capital, people, land...


Most cannabis companies won't survive the next three years. The ones that do will have better capital discipline, sharper regulatory reads, and operational frameworks built for compression, not growth. The Dime is where cannabis operators, executives, and investors hear directly from the CEOs and founders making those decisions right now: MSO strategy, state-by-state market dynamics, cultivation and extraction economics, brand positioning, and the financing structures keeping companies alive. Bryan Fields hosts weekly conversations built for operators, not observers.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
37%
Guest openness
Selective
Sign up to generate a grounded pitch for The Dime.
Signup to Generate a PitchMost cannabis companies won't survive the next three years. The ones that do will have better capital discipline, sharper regulatory reads, and operational frameworks built for compression, not growth.
Recent episodes include "How AYRLOOM Built Its Advantage in New York Cannabis ft. Eddie Brennan" (26 October 2026, 44 minutes), "Who Benefits From Federal Cannabis Limbo? ft. Jay Rosenthal" (14 October 2026, 53 minutes), and "What Makes Consumers Buy the Same Edible Again? ft. Kim Sanchez Rael" (30 September 2026, 42 minutes).
The Dime publishes roughly every two weeks, with episodes averaging 49 minutes.
Booking probability for The Dime is 37%, and the host is rated Selective on guests. The Dime requires a Pod Score of 80 or higher. The Dime's contact route on record: verified email.
The strongest fits for The Dime are Business & Management Consulting and Other Nondurable Goods Wholesale. The Dime has a business audience.
The Dime is a business podcast.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

A 115-year farm discovered that preserving the legacy meant letting a new crop compete with it. Ayrloom reached Beak & Skiff's revenue scale in three years, then forced the family to reallocate capital, people, land...

Federal cannabis reform is supposed to open the same door for everyone. The current market says otherwise. The largest operators do not share one political agenda, and some of the barriers they complain about are also...

Fast-acting edibles can command a premium, but labels such as "nano" do not prove the final product works. The larger operating question is whether the formulation improves taste, shelf stability, manufacturing...

Episode #307
Global expansion is often pitched as an opportunity. For an undisciplined cannabis company, it is an expensive way to expose every weakness at once. International markets reward specific operating capabilities, not...

Much of the licensed cannabis industry is quietly counting the volume it expects to inherit from the federal hemp ban coming this November. ** Now December. What they may not realize is that the ban could eliminate the...

AI has made software easier than ever to build. That does not mean every internal tool should become the backbone of your business. In this episode, Bryan sits down with Chris Guthrie to break down the growing...

Cannabis rescheduling is not as simple as “Trump rescheduled cannabis.” States are interpreting rescheduling completely differently depending on their license structure. These tiny details are widening the gap between...

Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has. Organigram CEO James Yamanaka came up over 20 years at British American Tobacco, where that discipline is the entire...

When a regulator asks what the downside is of adding one more testing requirement, what is the downside? Just a little more safe. Just in case. Especially when adding one more item to an already exhaustive testing...

Episode #301
The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention. CBD is not a panacea. When Charlotte's Web opened hearts and...

The number in your head and the number you actually need are not the same number. That gap is where most cannabis businesses break. Joe Lustberg has financed operators across the country for years and watched that gap...

Cannabis operators aren't short on data. They're drowning in it. The real problem is what happens when that data gets handed to the wrong person, read at the wrong time, or used to justify the wrong decision...

A customer walks into the dispensary and asks the budtender for a flower recommendation. They end up with a degraded version of the once high-end flower that graced your cultivation floor. They do not know it. Your...

Episode #297
The largest payment processor in the world handles cannabis in Canada. In the U.S., they will not touch it. That’s the gap. Aubrey Amatelli left JP Morgan believing that if you followed the rules, aligned with card...

Episode #296
Politics is a dirty business. Sometimes being feared is the influence you need because access is not the problem. Politicians say "we'll take care of this." Gretchen Gailey has a different approach: stab them in the...

Episode #295
Investing in cannabis requires a split personality. Everyone thinks they're early. Dan McDermitt has been trading the sector for 15 years — through the Canadian boom, the Biden promise, and the slow bleed that followed...

Most cannabis companies chased scale. Rubicon chased quality. What does it actually take to build a premium cannabis brand? Trust sits behind what “premium” really means, why consumers only give brands one chance, how...

Episode #293
When California legalized cannabis, did anyone see 70% of the state opting out. Retail access never recovered. The illicit market stayed durable. And taxes kept compounding pressure on operators. Micah Anderson, CEO of...

Episode #292
Everyone knows the Cheech & Chong name. Almost no one understands the infrastructure behind it. This isn’t a celebrity brand story. It’s a leverage story inside a fragmented, state-locked cannabis market that could...

Beverage may be the most approachable format in cannabis. Familiar ritual. Familiar packaging. Familiar context. Easily Sharable But familiarity creates comparison. Alcohol. That means safety, expectation, and education...
PitchCentric classifies The Dime under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

The Dime
Investing in Cannabis

Grassroots Marketing
The Ganjapreneur Podcast

DANK Discussions - Making More Money with Your Cannabis, Hemp, CBD Business

The Cannabis Business Coach
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ